Integrating Molecular Biomarker Inputs Into Development and Use of Clinical Cancer Therapeutics

Biomarkers can contribute to clinical cancer therapeutics at multiple points along the patient’s diagnostic and treatment course. Diagnostic biomarkers can screen or classify patients, while prognostic biomarkers predict their survival. Biomarkers can also predict treatment efficacy or toxicity and...

Descripción completa

Detalles Bibliográficos
Autores principales: Louie, Anna D., Huntington, Kelsey, Carlsen, Lindsey, Zhou, Lanlan, El-Deiry, Wafik S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560682/
https://www.ncbi.nlm.nih.gov/pubmed/34737704
http://dx.doi.org/10.3389/fphar.2021.747194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560682/
https://www.ncbi.nlm.nih.gov/pubmed/34737704
http://dx.doi.org/10.3389/fphar.2021.747194

Ejemplares similares